We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$148M
2
HUM icon
Humana
HUM
+$109M
3
META icon
Meta Platforms (Facebook)
META
+$102M
4
MSI icon
Motorola Solutions
MSI
+$89.2M
5
LOW icon
Lowe's Companies
LOW
+$82M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADPT icon
1126
Adaptive Biotechnologies
ADPT
$4.05B
– –
-97,230
Closed -$2.7M
ADT icon
1127
ADT
ADT
$5.49B
– –
-32,674
Closed -$142K
AGI icon
1128
Alamos Gold
AGI
$13.9B
– –
-34,839
Closed -$173K
AIRG icon
1129
Airgain
AIRG
$71.8M
– –
-1,800
Closed -$13K
AJG icon
1130
Arthur J. Gallagher & Co
AJG
$64.7B
– –
-83,543
Closed -$6.81M
AKRO
1131
DELISTED
Akero Therapeutics
AKRO
– –
-2,939
Closed -$62K
ALB icon
1132
Albemarle
ALB
$15.5B
– –
-874
Closed -$49K
ALL icon
1133
Allstate
ALL
$68.2B
– –
-27,601
Closed -$2.53M
ALLO icon
1134
Allogene Therapeutics
ALLO
$725M
– –
-149,235
Closed -$2.9M
ALNT icon
1135
Allient
ALNT
$1.92B
– –
-4,325
Closed -$68K
ALRM icon
1136
Alarm.com
ALRM
$2.79B
– –
-54,965
Closed -$2.14M
AMPH icon
1137
Amphastar Pharmaceuticals
AMPH
$895M
– –
-3,165
Closed -$47K
AMRX icon
1138
Amneal Pharmaceuticals
AMRX
$5.71B
– –
-14,894
Closed -$52K
AMX icon
1139
America Movil
AMX
$71.6B
– –
-166,965
Closed -$1.97M
ANET icon
1140
Arista Networks
ANET
$241B
– –
-2,860,960
Closed -$36.2M
ANIK icon
1141
Anika Therapeutics
ANIK
$276M
– –
-9,139
Closed -$264K
APD icon
1142
Air Products & Chemicals
APD
$68.6B
– –
-49,199
Closed -$9.82M
APPF icon
1143
AppFolio
APPF
$7.06B
– –
-3,267
Closed -$362K
AR icon
1144
Antero Resources
AR
$11.4B
– –
-1
Closed –
ARCC icon
1145
Ares Capital
ARCC
$14.3B
– –
-1,348
Closed -$15K
ARE icon
1146
Alexandria Real Estate Equities
ARE
$8.32B
– –
-3,910
Closed -$536K
AROC icon
1147
Archrock
AROC
$5.81B
– –
-883,992
Closed -$3.32M
ARQT icon
1148
Arcutis Biotherapeutics
ARQT
$3.26B
– –
-41,315
Closed -$1.23M
ASB icon
1149
Associated Banc-Corp
ASB
$5.92B
– –
-7,433
Closed -$95K
EFOR
1150
Everforth Inc
EFOR
$1.33B
– –
-1,271
Closed -$45K
44 45
46
47 48

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.